MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 761 to 780 of 166,322 approvalsPage 39 of 8317

Vonoprazan Fumarate Tablets

Approval Number: 国药准字H20253897
Registration: Apr 15, 2025
浙江康恩贝制药股份有限公司

Bisoprolol Fumarate Tablets

Approval Number: 国药准字H20253940
Registration: Apr 15, 2025
湖南千金湘江药业股份有限公司

Oseltamivir Phosphate for Suspension

Approval Number: 国药准字H20253902
Registration: Apr 15, 2025
遂成药业股份有限公司

Polyvinyl Alcohol Eye Drops

Approval Number: 国药准字H20253921
Registration: Apr 15, 2025
四川海梦智森生物制药有限公司

Lacosamide Tablets

Approval Number: 国药准字H20253870
Registration: Apr 15, 2025
浙江九洲药物科技有限公司

咳特灵胶囊

Approval Number: 国药准字Z41022183
Registration: Apr 15, 2025
南阳普康药业有限公司

Lincomycin Hydrochloride Injection

Approval Number: 国药准字H41022704
Registration: Apr 15, 2025
南阳普康药业有限公司

Timolol Maleate Eye Drops

Approval Number: 国药准字H20253876
Registration: Apr 15, 2025
合肥立方制药股份有限公司

Salbutamol Sulfate Injection

Approval Number: 国药准字H20253917
Registration: Apr 15, 2025
湖南华纳大药厂股份有限公司

Doxofylline Tablets

Approval Number: 国药准字H20253929
Registration: Apr 15, 2025
浙江高跖医药科技股份有限公司

Levetiracetam Oral Solution

Approval Number: 国药准字H20253937
Registration: Apr 15, 2025
陕西天宇制药有限公司

Nicorandil Tablets

Approval Number: 国药准字H20253932
Registration: Apr 15, 2025
湖南九典制药股份有限公司

Pravastatin Sodium Tablets

Approval Number: 国药准字H20253952
Registration: Apr 15, 2025
浙江诺得药业有限公司

Betamethasone Tablets

Approval Number: 国药准字H41022989
Registration: Apr 15, 2025
南阳普康药业有限公司

Methocarbamol Injection

Approval Number: 国药准字H20253875
Registration: Apr 15, 2025
江苏艾立康医药科技有限公司

Moroxydine Hydrochloride Injection

Approval Number: 国药准字H41024371
Registration: Apr 15, 2025
南阳普康药业有限公司

Norfloxacin Capsules

Approval Number: 国药准字H41022718
Registration: Apr 15, 2025
南阳普康药业有限公司

Indobufen Tablets

Approval Number: 国药准字H20253943
Registration: Apr 15, 2025
浙江百代医药科技有限公司

Bisoprolol Fumarate Tablets

Approval Number: 国药准字H20253939
Registration: Apr 15, 2025
湖南千金湘江药业股份有限公司

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.